N A N O L I P O B L O C K E R S
A new tactic to treat reoccurring blocked blood vessels in Heart Disease at Rutgers, in New Jersey. These Nanolipoblockers are used to reduce the build up of bad cholesterol in the body.
Developed by: Prabhas V. Moghe, Biomedical Engineering Professor, Rutgers University, in New Jersey.
High cholesterol is a major factor in Heart Disease.
Low density Lipoprotein or Bad Cholesterol builds up to become hardened vascular plaque that blocks arteries, which causes inflammation. The inflammation causes damage to the tissue around it. Which is soon attacked by white blood cells at the sight of the infection. The Nanolipoblockers created by the college team compete with the Bad Cholesterol by teaming up with the white blood cells, reducing the combined LDLs by up to 75%.
The research for this developmental treament is underway as of now, they've gathered a family of Nanolipoblockers and they are testing on animals. Mice to be specific.
I didn't come across any problems in my research of this type of Nanotechnology. They weren't identified in any of the documents I read to get my information.